Seminars in Nephrology
Volume 29, Issue 4 , Pages 389-398 , July 2009

Pediatric Nephrotic Syndrome: From the Simple to the Complex

  • Jerome C. Lane, MD

      Affiliations

    • Division of Kidney Diseases, Department of Pediatrics, Children's Memorial Hospital and Northwestern University Feinberg School of Medicine, Chicago, IL
    • Corresponding Author InformationAddress reprint requests to Jerome C. Lane, MD, Children's Memorial Hospital 2300 Children's Plaza, Box 37, Chicago, IL 60614
    • ,
  • Frederick J. Kaskel, MD, PhD

      Affiliations

    • Division of Pediatric Nephrology, Children's Hospital at Montefiore, Bronx, NY

References 

  1. Eddy AA, Schnaper HW. The nephrotic syndrome: from the simple to the complex. Semin Nephrol. 1998;18:304–316
  2. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69:2131–2147
  3. Kestila M, Lenkkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Moll Cell. 1998;4:575–582
  4. Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med. 2006;354:1387–1401
  5. Patrakka J, Tryggvason K. Nephrin—a unique structural and signaling protein of the kidney filter. Trends Mol Med. 2007;13:396–403
  6. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science. 2003;300:1298–1300
  7. Löwik MM, Groenen PJTA, Pronk I, Lilien MR, Goldschmeding R, Dijkman HB, et al. Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int. 2007;72:1198–1203
  8. D'Agati VD. The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens. 2008;17:271–281
  9. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. 2007;17:428–437
  10. Lehir M, Kriz W. New insights into structural patterns encountered in glomerulosclerosis. Curr Opin Nephrol Hypertens. 2007;16:184–191
  11. Aaltonen P, Holthöfer H. The nephrin-based slit diaphragm: new insight into the signaling platform identifies targets for therapy. Nephrol Dial Transplant. 2007;22:3408–3410
  12. Dai C, Stolz DB, Bastacky SI, St-Arnaud R, Wu C, Dedhar S, et al. Essential role of integrin-linked kinase in podocyte biology: bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol. 2006;17:2164–2175
  13. Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nurnberg G, et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet. 2006;38:1397–1404
  14. Pollak MR. Focal segmental glomerulosclerosis: recent advances. Curr Opin Nephrol Hypertens. 2008;17:138–142
  15. Gbadegesin R, Hinkes B, Vlangos C, Mucha B, Liu J, Hopcian J, et al. Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2007;22:509–513
  16. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, et al. Arbeitsgemeinschaft für Pädiatrische Nephrologie Study Group Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol. 2004;15:722–732
  17. Ruf RG, Schultheiss M, Lichtenberger A, Karle SM, Zalewski I, Mucha B, et al. APN Study Group Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int. 2004;66:564–570
  18. Coward RJ, Foster RR, Patton D, Ni L, Lennon R, Bates DO, et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol. 2005;16:629–637
  19. Uchida K, Suzuki K, Iwamoto M, Kawachi H, Ohno M, Horita S, et al. Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int. 2008;73:926–932
  20. Mathieson PW. Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant. 2003;18(Suppl 6:vi):26–29
  21. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629–639
  22. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis. 1994;23:574–581
  23. Andresdottir MB, Ajubi N, Croockewit S, Assmann KJ, Hibrands LB, Wetzels JF. Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant. 1999;14:2650–2656
  24. van den Berg JG, Weening JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci (Lond). 2004;107:125–136
  25. Niaudet P. Steroid-sensitive idiopathic nephrotic syndrome in children. In:  Avner E,  Harmon W,  Niaudet P editor. Pediatric nephrology. 5th ed.. Philadelphia: Lippincott, Williams & Wilkins; 2004;p. 543–556
  26. Brenchley PEC. Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2003;18(Suppl 6):vi21–vi25
  27. Savin VJ, Sharma R, Lovell HB, Welling DJ. Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol. 1992;3:1260–1269
  28. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med. 1996;334:878–883
  29. Sharma M, Sharma R, McCarthy ET, Savin VJ. ‘The FSGS factor’: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol. 1999;10:552–561
  30. Van Den Berg JG, Aten J, Chand MA, Claessen N, Dijkink L, Wijdenes J, et al. Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. J Am Soc Nephrol. 2000;11:413–422
  31. Parry RG, Gillespie KM, Mathieson PW. Effects of type 2 cytokines on glomerular epithelial cells. Exp Nephrol. 2001;9:275–283
  32. Aten J, Roos A, Claessen N, Schilder-Tol EJ, Ten Berge IJ, Weening JJ. Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol. 2000;11:1426–1438
  33. van den Berg JG, Aten J, Annink C, Ravesloot JH, Weber E, Weening JJ. Interleukin-4 and -13 promote basolateral secretion of H+ and cathepsin L by glomerular epithelial cells. Am J Physiol Renal Physiol. 2002;282:F26–F33
  34. Huwiler A, Ren S, Holthofer H, Pavenstadt H, Pfeilschifter J. Inflammatory cytokines upregulate nephrin expression in human embryonic kidney epithelial cells and podocytes. Biochem Biophys Res Commun. 2003;305:136–142
  35. Koukouritaki SB, Vardaki EA, Papakonstanti EA, Lianos E, Stournaras C, Emmanouel DS. TNF-α induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase. Mol Med. 1999;5:382–392
  36. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007;71:1205–1214
  37. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol. 2008;172:299–308
  38. Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, Kasinath BS, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Renal Physiol. 2002;283:F173–F180
  39. Hodson EM, Alexander SI. Evaluation and management of steroid-sensitive nephrotic syndrome. Curr Opin Pediatr. 2008;20:145–150
  40. Gipson DS, Gibson K, Gipson PE, Watkins S, Moxey-Mims M. Therapeutic approach to FSGS in children. Pediatr Nephrol. 2007;22:28–36

PII: S0270-9295(09)00052-7

doi: 10.1016/j.semnephrol.2009.03.015

Seminars in Nephrology
Volume 29, Issue 4 , Pages 389-398 , July 2009

Article Tools

* Image Usage & Resolution